SEARCH

SEARCH BY CITATION

References

  • 1
    Mera RM, Miller LA, Daniels JJ, Weil JG, White AR. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 2005; 51: 195200.
  • 2
    Bratu S, Landman D, Haag R et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005; 165: 14305.
  • 3
    Gould IM. Antibiotic policies and control of resistance. Curr Opin Infect Dis 2002; 15: 395400.
  • 4
    Neuhauser MM, Weinstein RA, Rydman R et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289: 8858.
  • 5
    Kawanami GH, Fortaleza CM. Factors predictive of inappropriateness in requests for parenteral antimicrobials for therapeutic purposes: a study in a small teaching hospital in Brazil. Scand J Infect Dis 2011; 43: 52835.
  • 6
    Cosgrove SE, Patel A, Song X et al. Impact of different methods of feedback to clinicians after post-prescription antimicrobial review based on the Centers For Disease Control and Prevention’s 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults. Infect Control Hosp Epidemiol 2007; 28: 6416.
  • 7
    Kisuule F, Wright S, Barreto J, Zenilman J. Improving antibiotic utilization among hospitalists: a pilot academic detailing project with a public health approach. J Hosp Med 2008; 3: 6470.
  • 8
    Arnold FW, McDonald LC, Smith RS, Newman D, Ramirez JA. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol 2006; 27: 37882.
  • 9
    Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 15977.
  • 10
    MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18: 63856.
  • 11
    Owens RC Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis 2008; 61: 11028.
  • 12
    Drew RH. Antimicrobial stewardship programs: how to start and steer a successful program. J Manag Care Pharm 2009; 15(Suppl): S1823.
  • 13
    Gilbert DN, Moellering RC, Eliopoulos GM et al. The Sanford Guide to Antimicrobial Therapy, 39th edn. Vermont: Antimicrobial Therapy, 2009.
  • 14
    Pulcini C, Defres S, Aggarwal I, Nathwani D, Davey P. Design of a ‘day 3 bundle’ to improve the reassessment of inpatient empirical antibiotic prescriptions. J Antimicrob Chemother 2008; 61: 13848.
  • 15
    Guidelines for ATC Classification and DDD Assignment 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2010. http://www.whocc.no/atcddd/ Published 2011 (accessed March 2011).
  • 16
    Cahill NE, Heyland DK. Bridging the guideline-practice gap in critical care nutrition: a review of guideline implementation studies. J Parenter Enteral Nutr 2010; 34: 653659.
  • 17
    Fraser GL, Stogsdill P, Dickens JD Jr et al. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157: 168994.
  • 18
    Srinivasan A, Song X, Richards A et al. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch Intern Med 2004; 164: 14516.
  • 19
    Evans RS, Pestotnik SL, Classen DC, Burke JP. Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother 1999; 33: 102631.
  • 20
    Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 8428.
  • 21
    Bantar C, Sartori B, Vesco E et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37: 1806.
  • 22
    Gyssens IC, Blok WL, van den Broek PJ, Hekster YA, van der Meer JW. Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine. Eur J Clin Microbiol Infect Dis 1997; 16: 90412.
  • 23
    Manuel O, Burnand B, Bady P et al. Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards. J Hosp Infect 2010; 74: 32631.
  • 24
    Philmon C, Smith T, Williamson S, Goodman E. Controlling use of antimicrobials in a community teaching hospital. Infect Control Hosp Epidemiol 2006; 27: 23944.
  • 25
    White AC Jr, Atmar RL, Wilson J et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25: 2309.
  • 26
    Takesue Y, Nakajima K, Ichiki K et al. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria. J Hosp Infect 2010; 75: 2832.
  • 27
    Ding H, Yang Y, Wei J et al. Influencing the use of antibiotics in a Chinese pediatric intensive care unit. Pharm World Sci 2008; 30: 787793.
  • 28
    Rybak MJ. Pharmacodynamics: relation to antimicrobial resistance. Am J Med 2006; 119(Suppl 1): S3744. discussion S62-70.
  • 29
    Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290: 258898.
  • 30
    Dunn K, O’Reilly A, Silke B, Rogers T, Bergin C. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm 2011; 33: 20814.